Miller Anestesia

2686 / 2894

116. Eker C, Asgeirsson B, Grande PO, et al: Improved
outcome after severe head injury with a new therapy
based on principles for brain volume regulation and
preserved microcirculation. Crit Care Med 26:
1881–1886, 1998.
117. Naredi S, Olivecrona M, Lindgren C, et al: An
outcome study of severe traumatic head injury
using the “Lund therapy” with low-dose prostacy-
clin. Acta Anaesthesiol Scand 45:402–406, 2001.
118. Edwards P, Arango M, Balica L, et al: Final results
of MRC CRASH, a randomised placebo-controlled
trial of intravenous corticosteroid in adults with
head injury—outcomes at 6 months. Lancet 365:
1957–1959, 2005.
119. DensonK, MorganD, CunninghamR, et al: Incidence
of venous thromboembolism in patients with trau-
matic brain injury. Am J Surg 193:380–383, 2007.
120. Macdonald RL, Amidei C, Baron J, et al: Randomi-
zed, pilot study of intermittent pneumatic compres-
sion devices plus dalteparin versus intermittent
pneumatic compression devices plus heparin for
prevention of venous thromboembolism in patients
undergoing craniotomy. Surg Neurol 59:363–372,
2003.
121. Wijdicks EF, Kallmes DF, Manno EM, et al: Suba-
rachnoid hemorrhage: Neurointensive care and
aneurysm repair. Mayo Clinic Proc 80:550–559,
2005.
122. Linn FH, Rinkel GJ, Algra A, van GJ: Incidence of
subarachnoid hemorrhage: Role of region, year, and
rate of computed tomography: A meta-analysis.
Stroke 27:625–629, 1996.
123. Mayberg MR, Batjer HH, Dacey R, et al: Guidelines
for the management of aneurysmal subarachnoid
hemorrhage: A statement for healthcare professio-
nals from a special writing group of the Stroke
Council. American Heart Association. Stroke 25:
2315–2328, 1994.
124. van GJ, Rinkel GJ: Subarachnoid haemorrhage:
Diagnosis, causes and management. Brain 124:249–
278, 2001.
125. Broderick JP, Brott TG, Duldner JE, et al: Initial and
recurrent bleeding are the major causes of death
following subarachnoid hemorrhage. Stroke 25:
1342–1347, 1994.
126. Dorsch NW: Therapeutic approaches to vasospasm
in subarachnoid hemorrhage. Curr Opin Crit Care
8:128–133, 2002.
127. Cesarini KG, Hardemark HG, Persson L: Improved
survival after aneurysmal subarachnoid hemorr-
hage: Review of case management during a 12-year
period. J Neurosurg 90:664–672, 1999.
128. Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ:
Impact of medical treatment on the outcome of
patients after aneurysmal subarachnoid hemorr-
hage. Stroke 29:924–930, 1998.
129. Berman MF, Solomon RA, Mayer SA, et al: Impact
of hospital-related factors on outcome after
treatment of cerebral aneurysms. Stroke 34:2200–
2207, 2003.
130. Hop JW, Rinkel GJ, Algra A, van GJ: Case-fatality
rates and functional outcome after subarachnoid
hemorrhage: A systematic review. Stroke 28:660–
664, 1997.
131. Haley EC Jr, Kassell NF, Torner JC: The Internatio-
nal Cooperative Study on the Timing of Aneurysm
Surgery. The North American experience. Stroke
23:205–214, 1992.
132. Ransom E, Mocco J, Komotar R, et al: External
ventricular drainage response in poor grade aneu-
rysmal subarachnoid hemorrhage: Effect on
preoperative grading and prognosis. Neurocritical
Care 6:174–180, 2007.
133. Roos Y, Rinkel G, Vermeulen M, et al: Antifibrino-
lytic therapy for aneurysmal subarachnoid hemorr-
hage: A major update of a Cochrane review. Stroke
34:2308–2309, 2003.
134. Aiyagari V, Powers WJ, Diringer MN: Cerebrovas-
cular disease. In Schmidt GA, Hall JB, Wood LDH
(eds): Principles of Critical Care, 3rd ed. New York,
McGraw-Hill Professional, 2005, pp 985–996.
135. Suhardja A: Mechanisms of disease: Roles of nitric
oxide and endothelin-1 in delayed cerebral vasos-
pasm produced by aneurysmal subarachnoid
hemorrhage. Nat Clin Pract Cardiovasc Med 1:110–
116, 2004.
136. de Oliveira JG, Beck J, Ulrich C, et al: Comparison
between clipping and coiling on the incidence of cere-
bral vasospasmafter aneurysmal subarachnoid hemo­
rrhage: A systematic review and meta-analysis.
Neurosurg Rev 30:22–30, 2007.
137. Denny-Brown D: The treatment of recurrent cere-
brovascular symptoms and the question of “vasos-
pasm”. Med Clin North Am 35:1457–1474, 1951.
138. Wise G, Sutter R, Burkholder J: The treatment of
brain ischemia with vasopressor drugs. Stroke
3:135–140, 1972.
139. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment
of ischemic deficits from vasospasm with intravas-
cular volume expansion and induced arterial hyper-
tension. Neurosurgery 11:337–343, 1982.
140. Naidech AM, Jovanovic B, Wartenberg KE, et al:
Higher hemoglobin is associated with improved
outcome after subarachnoid hemorrhage. Crit Care
Med 35:2383–2389, 2007.
141. Treggiari MM, Walder B, Suter PM, Romand JA:
Systematic review of the prevention of delayed
ischemic neurological deficits with hypertension,
hypervolemia, and hemodilution therapy following
subarachnoidhemorrhage.JNeurosurg98:978–984,
2003.
142. Rinkel GJ, Feigin VL, Algra A, van Gijn J: Circula-
tory volume expansion therapy for aneurysmal
subarachnoid haemorrhage. Cochrane Database
Syst Rev 4, 2004, CD000483.
143. Egge A, Waterloo K, Sjoholm H, et al: Prophylactic
hyperdynamic postoperative fluid therapy after
aneurysmal subarachnoid hemorrhage: A clinical,
prospective, randomized, controlled study. Neuro-
surgery 49:593–605, 2001.
144. Muench E, Horn P, Bauhuf C, et al: Effects of hyper-
volemia and hypertension on regional cerebral
blood flow, intracranial pressure, and brain tissue
oxygenation after subarachnoid hemorrhage. Crit
Care Med 35:1844–1851, 2007.
145. Smith MJ, Le Roux PD, Elliott JP, Winn HR: Blood
transfusion and increased risk for vasospasm and
poor outcome after subarachnoid hemorrhage. J
Neurosurg 101:1–7, 2004.
146. Vincent JL, Baron JF, Reinhart K, et al: Anemia and
blood transfusion in critically ill patients. JAMA
288:1499–1507, 2002.
147. Dorhout Mees SM, Rinkel G, Feigin V, et al:
Calcium antagonists for aneurysmal subarachnoid
haemorrhage. Cochrane Database Syst Rev 3,
CD000277, 2007.
148. Dorhout Mees SM, Rinkel GJ, Hop JW, et al: Anti-
platelet therapy in aneurysmal subarachnoid hemo-
rrhage: A systematic review. Stroke 34:2285–2289,
2003.
149. Tseng MY, Czosnyka M, Richards H, et al: Effects of
acute treatment with pravastatin on cerebral vasos-
pasm, autoregulation, and delayed ischemic deficits
after aneurysmal subarachnoid hemorrhage: A
phase II randomized placebo-controlled trial. Stroke
36:1627–1632, 2005.
150. Lynch JR, Wang H, McGirt MJ, et al: Simvastatin
reduces vasospasm after aneurysmal subarachnoid
hemorrhage: Results of a pilot randomized clinical
trial. Stroke 36:2024–2026, 2005.
151. Vajkoczy P, Meyer B, Weidauer S, et al: Clazosentan
(AXV-034343), a selective endothelin A receptor
antagonist, in the prevention of cerebral vasospasm
following severe aneurysmal subarachnoid hemorr-
double-blind,placebo-
controlled, multicenter phase IIa study. J Neurosurg
103:9–17, 2005.
152. Eskridge JM, McAuliffe W, Song JK, et al: Balloon
angioplasty for the treatment of vasospasm: Results
of first 50 cases. Neurosurgery 42:510–516, 1998.
153. Bejjani GK, Bank WO, Olan WJ, Sekhar LN: The
efficacy and safety of angioplasty for cerebral vasos-
pasm after subarachnoid hemorrhage. Neurosur-
gery 42:979–986, 1998.
154. Elliott JP, Newell DW, Lam DJ, et al: Comparison of
balloon angioplasty and papaverine infusion for the
treatment of vasospasm following aneurysmal
subarachnoidhemorrhage.JNeurosurg88:277–284,
1998.
155. Manninen PH, Ayra B, Gelb AW, Pelz D: Association
between electrocardiographic abnormalities and
intracranial blood in patients following acute suba-
rachnoid hemorrhage. J Neurosurg Anesthesiol
7:12–16, 1995.
156. Szabo MD, Crosby G, Hurford WE, Strauss HW:
Myocardial perfusion following acute subarachnoid
hemorrhage in patients with an abnormal electro-
cardiogram. Anesth Analg 76:253–258, 1993.
157. Mayer SA, Lin J, Homma S, et al: Myocardial injury
and left ventricular performance after subarachnoid
hemorrhage. Stroke 30:780–786, 1999.
158. Jain R, Deveikis J, Thompson BG: Management of
patients with stunned myocardium associated with
subarachnoid hemorrhage. AJNR Am J Neuroradiol
25:126–129, 2004.
159. Lee VH, Connolly HM, Fulgham JR, et al: Tako-
tsubo cardiomyopathy in aneurysmal subarachnoid
hemorrhage: An underappreciated ventricular dys-
function. J Neurosurg 105:264–270, 2006.
160. Schuiling WJ, Dennesen PJW, Tans JT, et al: Tropo-
nin I in predicting cardiac or pulmonary compli-
cations and outcome in subarachnoid haemorrhage.
J Neurol Neurosurg Psychiatry 76:1565–1569,
2005.
161. Zaroff JG, Pawlikowska L, Miss JC, et al: Adreno-
ceptor polymorphisms and the risk of cardiac
injury and dysfunction after subarachnoid hemorr-
hage. Stroke 37:1680–1685, 2006.
162. Gruber A, Reinprecht A, Gorzer H, et al: Pulmonary
function and radiographic abnormalities related to
neurological outcome after aneurysmal subarach-
noid hemorrhage. J Neurosurg 88:28–37, 1998.
163. Kahn JM, Caldwell EC, Deem S, et al: Acute lung
injury in patients with subarachnoid hemorrhage:
Incidence, risk factors, and outcome. Crit Care Med
34:196–202, 2006.
164. Frontera JA, Fernandez A, Claassen J, et al: Hyper-
glycemia after SAH: Predictors, associated compli-
cations, and impact on outcome. Stroke 37:199–203,
2006.
165. Charpentier C, Audibert G, Guillemin F, et al: Mul-
tivariate analysis of predictors of cerebral vasos-
pasm occurrence after aneurysmal subarachnoid
hemorrhage. Stroke 30:1402–1408, 1999.
166. Gandhi GY, Nuttall GA, Abel MD, et al: Intensive
intraoperative insulin therapy versus conventional
glucose management during cardiac surgery: A
randomized trial. Ann Intern Med 146:233–243,
2007.
167. Feigin VL, Anderson N, Rinkel GJ, et al: Corticos-
teroids for aneurysmal subarachnoid haemorrhage
and primary intracerebral haemorrhage. Cochrane
Database Syst Rev 3, 2005, CD004583.
168. Harrigan MR: Cerebral salt wasting syndrome:
A review. Neurosurgery 38:152–160, 1996.
169. Qureshi AI, Suri MF, Sung GY, et al: Prognostic
significance of hypernatremia and hyponatremia
among patients with aneurysmal subarachnoid
hemorrhage. Neurosurgery 50:749–755, 2002.
170. Berendes E, Walter M, Cullen P, et al: Secretion of
brain natriuretic peptide in patients with aneurys-
mal subarachnoid haemorrhage. Lancet 349:245–
249, 1997.
171. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J:
Hyponatremia and cerebral infarction in patients
with ruptured intracranial aneurysms: Is fluid res-
triction harmful? Ann Neurol 17:137–140, 1985.
172. Igarashi T, Moro N, Katayama Y, et al: Prediction of
symptomatic cerebral vasospasm in patients with
aneurysmal subarachnoid hemorrhage: Relations-
hip to cerebral salt wasting syndrome. Neurol Res
29:835–841, 2007.
173. Sherlock M, O’Sullivan E, Agha A, et al: The inci-
dence and pathophysiology of hyponatraemia after
subarachnoid haemorrhage. Clin Endocrinol (Oxf)
64:250–254, 2006.
174. Cowley AW Jr, Roman RJ: Control of blood and
extracellular volume. Baillieres Clin Endocrinol
Metab 3:331–369, 1989.
2686 Cuidados críticos VII